de Mol, Mark
Visser, Sabine
Aerts, Joachim
Lodder, Paul
van Walree, Nico
Belderbos, Huub
den Oudsten, Brenda
Funding for this research was provided by:
ZonMW (152001017)
Article History
Received: 7 May 2019
Accepted: 2 April 2020
First Online: 18 May 2020
Ethics approval and consent to participate
: Written informed consent was obtained from all individual participants included in the study. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board of the Erasmus University Medical Center in Rotterdam, the Netherlands (MEC-2012-232).
: Not applicable.
: The authors declare that they have no competing interests except J. Aerts. J. Aerts has received personal fees as a speaker for/member of the advisory board of Eli Lilly.